Damon Runyon Rachleff Innovation Award

See Complete Announcement at
http://www.damonrunyon.org/for_scientists/more/innovation_award_overview#eligibility


Program Description

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high risk/high reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.
The Innovation award is specifically designed to provide funding for extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.
Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. All awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Innovation Award Committee.

Funding•

The award will be for a period of three years. Each award will provide a total of $450,000 in direct costs. The Award cannot be used for indirect costs or institutional overhead.•Awards will be paid in increments of $150,000 per year for three years. However, the Innovation Award Committee will consider an accelerated payment schedule if an award recipient can demonstrate compelling need.
•The Innovation Award funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s salary, salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research.
•The submitted budgets should be realistic estimates of the funds required for the proposed research and be itemized by category according to the instructions on the budget form.
•No part of this award may be used for indirect costs or institutional overhead.